NO20080182L - Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekning - Google Patents

Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekning

Info

Publication number
NO20080182L
NO20080182L NO20080182A NO20080182A NO20080182L NO 20080182 L NO20080182 L NO 20080182L NO 20080182 A NO20080182 A NO 20080182A NO 20080182 A NO20080182 A NO 20080182A NO 20080182 L NO20080182 L NO 20080182L
Authority
NO
Norway
Prior art keywords
treatment
pneumonia
prodrugs
steroids
precipitate
Prior art date
Application number
NO20080182A
Other languages
English (en)
Norwegian (no)
Inventor
William R Baker
Marcin Stasiak
Bruce Charles Girton
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of NO20080182L publication Critical patent/NO20080182L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/12Esters of phosphoric acids with hydroxyaryl compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO20080182A 2005-06-14 2008-01-11 Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekning NO20080182L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69054505P 2005-06-14 2005-06-14
PCT/US2006/022790 WO2006138212A1 (en) 2005-06-14 2006-06-12 SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND β -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION

Publications (1)

Publication Number Publication Date
NO20080182L true NO20080182L (no) 2008-02-21

Family

ID=37570763

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080182A NO20080182L (no) 2005-06-14 2008-01-11 Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekning

Country Status (14)

Country Link
US (1) US20100209508A1 (es)
EP (1) EP1893220A4 (es)
JP (1) JP2008546694A (es)
KR (1) KR20060130515A (es)
CN (1) CN101227912A (es)
AR (1) AR054475A1 (es)
AU (1) AU2006259604A1 (es)
BR (1) BRPI0611567A2 (es)
CA (1) CA2612364A1 (es)
IL (1) IL187816A0 (es)
NO (1) NO20080182L (es)
RU (1) RU2008100237A (es)
TW (1) TW200718707A (es)
WO (1) WO2006138212A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158780B2 (en) 2006-09-19 2012-04-17 Cipla Limited Processes for the preparation of ciclesonide and its crystal modification
JP2010513277A (ja) * 2006-12-13 2010-04-30 ギリード・サイエンシズ・インコーポレーテッド COPDおよび慢性気管支炎の治療のためのムスカリン受容体アンタゴニストおよびβ−アゴニストの共通プロドラッグとしてのモノホスフェート
JP2010513276A (ja) * 2006-12-13 2010-04-30 ギリード・サイエンシズ・インコーポレーテッド 肺炎症および気管支収縮の治療のための抗炎症シグナル伝達モジュレーター(AISTM)およびβ−アゴニストの相互プロドラッグとしてのモノホスフェート
US8524697B2 (en) 2007-12-21 2013-09-03 Merck Sharp & Dohme Corp. C20-C21 substituted glucocorticoid receptor agonists
WO2009085880A2 (en) * 2007-12-21 2009-07-09 Schering Corporation C-21 thioethers as glucocorticoid receptor agonists
AR074148A1 (es) * 2008-06-10 2010-12-29 Gilead Sciences Inc Derivados de corticoesteroides beta agonistas fosforilados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades del aparato respiratorio
WO2010126953A1 (en) * 2009-04-29 2010-11-04 Gilead Sciences, Inc. Corticosteroid linked beta-agonist compounds for use in therapy
WO2010132743A1 (en) * 2009-05-15 2010-11-18 Gilead Sciences, Inc. Corticosteroid beta-agonist compounds for use in therapy
US20120171126A1 (en) * 2009-06-16 2012-07-05 Purakkattle Biju J NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF
ME01331B (me) * 2009-09-11 2013-12-20 Chiesi Farm Spa Derivati izoksazolidina
WO2011081937A1 (en) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
JP6124176B2 (ja) * 2013-03-26 2017-05-10 株式会社伏見製薬所 樹脂成形体用組成物
CN104510726A (zh) * 2013-09-27 2015-04-15 张金华 一种用于清洁呼吸道系统的食盐干粉吸入剂
PT107567B (pt) * 2014-03-31 2019-02-13 Hovione Farm S A Secador por atomização com atomizador múltiplo, método para o aumento de escala de pós para inalação secos por dispositivo de atomização múltiplo e uso de vários atomizadores num secador por atomização
BR112018074922B1 (pt) 2016-06-02 2022-10-25 Abbvie Inc Compostos agonistas de receptores de glucocorticoides, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos
MX2019005330A (es) * 2016-11-08 2019-09-11 Regeneron Pharma Esteroides y conjugados de proteinas de los mismos.
EP3624894A1 (en) 2017-05-18 2020-03-25 Regeneron Pharmaceuticals, Inc. Cyclodextrin protein drug conjugates
RS61994B1 (sr) 2017-12-01 2021-07-30 Abbvie Inc Agonist glukokortikoidnog receptora i njegovi imunokonjugati
KR20200108002A (ko) 2018-01-08 2020-09-16 리제너론 파마슈티칼스 인코포레이티드 스테로이드 및 이의 항체-접합체
US11377502B2 (en) 2018-05-09 2022-07-05 Regeneron Pharmaceuticals, Inc. Anti-MSR1 antibodies and methods of use thereof
IT201900014178A1 (it) * 2019-08-06 2021-02-06 Genetic S P A Esteri del montelukast e loro formulazioni farmaceutiche
CN112592280B (zh) * 2020-12-09 2023-05-23 青岛职业技术学院 一种消旋沙丁胺醇的制备方法
TW202304462A (zh) 2021-03-23 2023-02-01 美商美國禮來大藥廠 糖皮質素受體激動劑
AR125079A1 (es) 2021-03-23 2023-06-07 Lilly Co Eli Agonistas de receptores de glucocorticoides sustituidos con carboxi
JP2024523545A (ja) * 2021-06-24 2024-06-28 江蘇先声薬業有限公司 ステロイド系化合物、その医薬組成物及びその応用
WO2023040793A1 (zh) * 2021-09-14 2023-03-23 映恩生物制药(苏州)有限公司 一种抗炎症的化合物及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE585432A (fr) * 1958-12-08 1960-06-08 American Cyanamid Co Stéroïdes fluorés.
US4757079A (en) * 1986-06-24 1988-07-12 Dynamac Corporaton Anti-hypertensive piperidine compounds
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
ES2124884T3 (es) * 1993-04-02 1999-02-16 Byk Gulden Lomberg Chem Fab Nuevos derivados de prednisolona.
US6300326B1 (en) * 1994-11-02 2001-10-09 Michael R. Dobbs Composition and method for control and treatment of cutaneous inflammation
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
WO2004103379A1 (en) * 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination
WO2005028495A1 (en) * 2003-09-24 2005-03-31 Glaxo Group Limited Anti-inflammatory glucocorticoids
WO2005063777A1 (en) * 2003-12-23 2005-07-14 Corus Pharma Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation

Also Published As

Publication number Publication date
JP2008546694A (ja) 2008-12-25
BRPI0611567A2 (pt) 2016-11-16
CA2612364A1 (en) 2006-12-28
EP1893220A4 (en) 2011-06-15
IL187816A0 (en) 2008-08-07
RU2008100237A (ru) 2009-07-20
WO2006138212A1 (en) 2006-12-28
EP1893220A1 (en) 2008-03-05
AR054475A1 (es) 2007-06-27
AU2006259604A1 (en) 2006-12-28
TW200718707A (en) 2007-05-16
KR20060130515A (ko) 2006-12-19
CN101227912A (zh) 2008-07-23
US20100209508A1 (en) 2010-08-19

Similar Documents

Publication Publication Date Title
NO20080182L (no) Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekning
NO20061254L (no) Farmasoytiske blandinger
WO2005063777A8 (en) Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
WO2009086470A3 (en) Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
HRP20130052T1 (hr) Lijeäśenje respiratorne bolesti
WO2012047674A3 (en) Methods and compositions for disease treatment using inhalation
NO20076561L (no) Imidazoquinoliner som lipid kinaseinhibitorer
BR112012023578A2 (pt) derivado de piridina e pirazina para o tratamento de cf
WO2012031603A3 (en) Airway administration of angiogenesis inhibitors
CA2905975A1 (en) Methods for treating respiratory diseases and formulations therefor
WO2011141929A3 (en) Aqueous pharmaceutical compositions of fluticasone and olopatadine
RS54241B1 (en) INHALATION COMPONENT CONTAINING ACLIDINIUM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE
WO2009099998A3 (en) Therapeutic treatment for lung conditions
SG10201806681YA (en) Amide compound and use thereof as agent for the treatment and prevention of diseases caused by rna- and/or dna-containing viruses, and concomitant diseases
Prabhu et al. Inhibition of metastatic lung cancer in C57BL/6 mice by marine mangrove Rhizophora apiculata
MX2020007971A (es) Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar.
BR112012000101B8 (pt) carboidratos medicinais para tratamento de condições respiratórias
MX2009013926A (es) Compuestos de etinilindol.
WO2016004395A1 (en) Sore-throat compositions and related methods
BR112012030930A2 (pt) fatores de trevo (tff) para tratamento de doenças pulmonares crônicas.
WO2006136962A3 (en) Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract
CN111065386A (zh) 减轻肺部感染的方法
BRPI0413968A (pt) composto de anel condensado e seu uso
WO2008076269A3 (en) MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS
van der Velden et al. Airway Remodeling In House Dust Mite-Induced Allergic Airway Disease

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application